サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1159155

制吐薬の世界市場（2022年～2028年）

Antiemetics Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
制吐薬の世界市場（2022年～2028年）
出版日: 2022年09月15日
発行: Orion Market Research
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の制吐薬の市場規模は、予測期間中に5.7%のCAGRで成長すると予想されています。がん患者数の増加、手術件数の増加、胃腸炎などの疾患の発生率の増加は、市場の成長を促進しています。

当レポートでは、世界の制吐薬市場について調査分析し、市場概要、競合情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • AstellasPharma Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline plc
  • Merck KGaA
  • 主要戦略分析
  • COVID-19が主要企業に与える影響

第4章 市場セグメンテーション

  • 世界の制吐薬市場：薬剤クラス別
    • 5-HT3受容体拮抗薬
    • 抗コリン薬
    • ベンゾジアゼピン
    • カンナビノイド
    • その他
  • 世界の制吐薬市場：用途別
    • 化学療法
    • 胃腸炎
    • 全身麻酔
    • 妊娠
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 世界のその他の地域

第6章 企業プロファイル

  • AbbottLaboratories
  • BaxterInternational Inc.
  • Bristol Myers Squibb
  • Cipla Ltd.
  • IPCA Labs
  • Johnson & Johnson
  • Novartis AG
  • Pfizer
  • Reddy Laboratories Ltd.
  • Sanofi SA
図表

LIST OF TABLES

  • 1. GLOBAL ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 2. GLOBAL 5-HT3 RECEPTOR ANTAGONISTS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL ANTICHOLINERGICS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL BENZODIAZEPINES ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL CANNABINOIDS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL STEROIDS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 8. GLOBALCHEMOTHERAPY ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL GASTROENTERITIS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL GENERAL ANAESTHETICS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL PREGNANCY ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL FOOD POISONING ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBALANTIEMETICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN ANTIEMETICSMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 15. NORTH AMERICAN ANTIEMETICSMARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 17. EUROPEAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. EUROPEAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 19. EUROPEAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. ASIA-PACIFIC ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 22. ASIA-PACIFIC ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 24. REST OF THE WORLD ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 25. REST OF THE WORLD ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL ANTIEMETICS MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL ANTIEMETICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL ANTIEMETICS MARKET, 2021-2028 (%)
  • 4. GLOBAL ANTIEMETICS MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
  • 5. GLOBAL 5-HT3 RECEPTOR ANTAGONISTS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL ANTICHOLINERGICS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL BENZODIAZEPINES ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL CANNABINOIDS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL STEROIDS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL ANTIEMETICS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 11. GLOBAL CHEMOTHERAPY ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL GASTROENTERITIS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL GENERAL ANAESTHETICS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL PREGNANCY ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL FOOD POISONING ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. US ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CANADA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. UK ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. FRANCE ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. GERMANY ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. ITALY ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. SPAIN ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. REST OF EUROPE ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. INDIA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. CHINA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. JAPAN ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. SOUTH KOREA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2025676

Global Antiemetics Market Size, Share & Trends Analysis Report by Drug Class (5-HT3 receptor antagonists, Anticholinergics, Benzodiazepines, Cannabinoids, and Others), and by Application (Chemotherapy, Gastroenteritis, General Anesthetics, Pregnancy, and Others) Forecast 2022-2028

The global antiemetics market is anticipated to grow at a substantial CAGR during the forecast period. The global antiemetics market is growing due to rising number of cancer patients and the raising number of surgeries. Manufacturers are exploiting nanotechnology in the antiemetics to deliver therapeutic agents to specific targeted sites in a controlled manner through Nano medicine and Nano delivery systems. Nano medicine is the medical application of nanotechnology which uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures and systems by controlled manipulation of size and shape at the nanometer scale. Such innovations are expected to offer lucrative opportunities to the market growth.

The global antiemetics market is segmented based on the drug class and application. Based on the drug class, the market is segmented into5-HT3 receptor antagonists, anticholinergics, benzodiazepines, cannabinoids, others. Based on the application, the market is sub-segmented into chemotherapy, gastroenteritis, general anesthetics, pregnancy, and others. The above-mentioned segments can be customized as per the requirements. Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America held considerable share in the market. The Asia-Pacific is the fastest increasing market due to the increasing cancer population, high incidence of gastroenteritis, and other diseases.

The major companies serving the global antiemetics market include GlaxoSmithKline plc, Merck KGaA, Eli Lilly and Co., Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers &acquisitions, collaborations, funding, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global antiemetics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Antiemetics Market Research and Analysis by Drug Class.

2. Global Antiemetics Market Research and Analysis by Application.

The Report Covers:

  • Comprehensive Research Methodology of the global antiemetics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global antiemetics market.
  • Insights about market determinants that are stimulating the global antiemetics market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on heGlobal Antiemetics Market
  • Recovery Scenario of Global Antiemetics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. AstellasPharma Inc.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Eli Lilly and Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GlaxoSmithKline plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Merck KGaA
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis
  • 3.6. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Antiemetics Market by Drug Class
    • 4.1.1. 5-HT3 receptor antagonists
    • 4.1.2. Anticholinergics
    • 4.1.3. Benzodiazepines
    • 4.1.4. Cannabinoids
    • 4.1.5. Others
  • 4.2. Global Antiemetics Market by Application
    • 4.2.1. Chemotherapy
    • 4.2.2. Gastroenteritis
    • 4.2.3. General anesthetics
    • 4.2.4. Pregnancy
    • 4.2.5. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AbbottLaboratories
  • 6.2. BaxterInternational Inc.
  • 6.3. Bristol Myers Squibb
  • 6.4. Cipla Ltd.
  • 6.5. IPCA Labs
  • 6.6. Johnson & Johnson
  • 6.7. Novartis AG
  • 6.8. Pfizer
  • 6.9. Reddy Laboratories Ltd.
  • 6.10. Sanofi SA

*List not Exhaustive**